The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

advaccine.com

Stage

Series B - II | Alive

Total Raised

$99.74M

Last Raised

$66M | 1 yr ago

About Advaccine

Advaccine is a biotech company that focuses on preventative and therapeutic vaccines.

Advaccine Headquarter Location

26 Xinxi Rd. Shangdi

Beijing, Beijing,

China

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Advaccine

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Advaccine is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Advaccine Patents

Advaccine has filed 1 patent.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • G protein coupled receptors
  • Immune system
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/5/2020

Immunology, G protein coupled receptors, Immune system, Clusters of differentiation, Vaccines

Application

Application Date

8/5/2020

Grant Date

Title

Related Topics

Immunology, G protein coupled receptors, Immune system, Clusters of differentiation, Vaccines

Status

Application

Latest Advaccine News

In the clinic for Oct. 13, 2021

Oct 14, 2021

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Advaccine, Aerie, Agenus, Apeiron, Arcturus, Ascletis, Astellas, BMS, Inflarx, Inhibrx, Inovio, Istari, Otonomy, Vtv.

  • Where is Advaccine's headquarters?

    Advaccine's headquarters is located at 26 Xinxi Rd., Beijing.

  • What is Advaccine's latest funding round?

    Advaccine's latest funding round is Series B - II.

  • How much did Advaccine raise?

    Advaccine raised a total of $99.74M.

  • Who are the investors of Advaccine?

    Investors of Advaccine include Matrix Partners China, StarCapital, Wosheng Investment, Hony Capital, Star Sky Investment and 6 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.